Old Web
English
Sign In
Acemap
>
authorDetail
>
Steven Porter
Steven Porter
Virology
Medicine
Hepatitis C virus
Ribavirin
Peginterferon alfa-2a
5
Papers
117
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Antiviral Activity of Danoprevir (ITMN-191/RG7227) in Combination With Pegylated Interferon α-2a and Ribavirin in Patients With Hepatitis C
2011
The Journal of Infectious Diseases
Nicole Forestier
Dominique Larrey
Patrick Marcellin
Dominique Guyader
Alain Patat
Regine Rouzier
P. Smith
Xiaoli. Qin
Sharlene Lim
Williamson Bradford
Steven Porter
Scott D. Seiwert
Stefan Zeuzem
Show All
Source
Cite
Save
Citations (18)
Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: A phase 1b multiple ascending dose study
2011
Journal of Hepatology
Nicole Forestier
Dominique Larrey
Dominique Guyader
Patrick Marcellin
Regine Rouzier
Alain Patat
P. Smith
Williamson Bradford
Steven Porter
Lawrence M. Blatt
Scott D. Seiwert
Stefan Zeuzem
Show All
Source
Cite
Save
Citations (62)
85 ANTIVIRAL ACTIVITY AND SAFETY OF ITMN-191 IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV)
2009
Journal of Hepatology
Nicole Forestier
D. Larrey
P. Marcellin
Y. Benhamou
Dominique Guyader
Williamson Bradford
Steven Porter
Alain Patat
Regine Rouzier
Stefan Zeuzem
Show All
Source
Cite
Save
Citations (22)
1